Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
bullish
New Horizon Health
Watchlist
New Horizon Health Placement (6606.HK) - Things Start to Get on Track, but There Are Still Concerns
Equity Capital Markets
376 Views
19 Jan 2023 01:11
New Horizon Health is starting to get on track, with practical development strategy. But whether high growth is sustainable and where's its valuation ceiling depend on how well educated the market is.
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 4-minute read)
Related Insights
More »
Loading
Trending Collections
More »
Index Rebalance
India
Event-Driven
Japan
China
Equity Bottom-Up
South Korea
Asia Event-Driven
Asia ECM
Sell / Short Ideas
Trending Insights
More »
Santos Ltd (STO AU): FIRB Approval For XRG's Tilt Will Be No Pushover
Gold Miners ETF (GDX US): BIG Impact of Benchmark Change
SET50 Index Rebalance: Four Changes in Two Weeks; DELTA Capping Too
Nakano Refrigerators (6411 JP): Marunouchi Capital’s JPY7,900 Tender Offer
Shin Kong (2888 TT)/Taishin (2887 TT) - Short Timer, FX Risk, Index Flows - Time To Buy Vs Peers
Top Unpaywalled Insights
More »
Overview #27 – The Big Beautiful Tragi-Comedy Continues
HK Connect SOUTHBOUND Flows (To 13 June 2025); Volumes Up, TECH Down, HEALTHCARE Bought Big
[IO Technicals 2025/24] Downward Momentum Lingers
China A-Share Consumer Staples: An Analysis of the Opportunities Ahead
Bearishness Persist in Soybeans Despite Rebound Hopes
Discussions
(Paid Plans Only)
Price Chart
(Sign Up to Access)
Insight Stream
Pre-IPO Shanghai Cell Therapy Group - Commercialization Prospects and Profitability Are Pessimistic
23 May 2024
CARSgen Therapeutics (2171.HK) - Pain Points Have Not Been Effectively Resolved
01 Jun 2023
New Horizon Health (6606.HK) - What Makes a Really Good Story? Definitely Not Just Breakeven
29 May 2023
New Horizon Health Placement (6606.HK) - Things Start to Get on Track, but There Are Still Concerns
19 Jan 2023
Wuxi Biologics Placement (2269 HK) - Things Are No Longer Easy When the Magic of CXO Wears Off
18 Jan 2023
Aier Eye Hospital Group (300015.CH) - The Truth Behind the Mirage
17 Jan 2023
Ascentage Pharma (6855.HK) - May Not Survive "This Winter"
22 Nov 2022
Top
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.3
x